Rosalind Wilson

Director Técnico/Científico/I+D en PRESCIENT THERAPEUTICS LIMITED .

Consumer Services

Health Technology

Non-Energy Minerals

Perfil

Rosalind Wilson is currently Chief Medical Officer at Prescient Therapeutics Ltd. since 2026.
Former roles include Chief Executive Officer at Invert Graphite Ltd. from 2017 to 2019 and Non-Executive Director at AdAlta Ltd. from 2019 to 2020.
Education includes a doctorate from Monash University and an MBA from London Business School.

Cargos activos de Rosalind Wilson

Empresas	Cargo	Inicio
PRESCIENT THERAPEUTICS LIMITED	Director Técnico/Científico/I+D	13/07/2026

Todos los cargos activos de Rosalind Wilson

Antiguos cargos conocidos de Rosalind Wilson.

Empresas	Cargo	Fin
ADALTA LIMITED	Director/Miembro de la Junta	27/03/2020
INVERT GRAPHITE LIMITED	Director Ejecutivo	25/01/2019

Ver el detalle de la experiencia de Rosalind Wilson.

Formación de Rosalind Wilson.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Rosalind Wilson.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
Invert Graphite Ltd. Invert Graphite Ltd. Construction MaterialsNon-Energy Minerals Engages in mining of lime and other minerals	Non-Energy Minerals
Prescient Therapeutics Ltd. Prescient Therapeutics Ltd. BiotechnologyHealth Technology Operates as a a clinical stage oncology company	Health Technology
Monash University Monash University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
London Business School London Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AdAlta Ltd. AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases	Health Technology